一株白马拟无枝酸菌潜在新种（Amycolatopsis baimaensis）WQ 127309及其应用
The isolation and identification of a new species of Amylopectinus baimai WQ 127309 has solved the problems of existing antibiotic resistance and insufficient development of antitumor drugs, and provided new antibiotics and drug resources with broad-spectrum antibacterial and antitumor activities.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- YUNNAN UNIV
- Filing Date
- 2024-09-30
- Publication Date
- 2026-07-17
AI Technical Summary
The widespread use of existing antibiotics has led to increased bacterial resistance, slowed down the development of new antibiotics, and the secondary metabolites of Amylopectinobacterium have not been fully explored, resulting in a lack of effective broad-spectrum antibacterial and antitumor active substances.
A novel species of Amycolatopsis, Amycolatopsis baimaensis WQ 127309, was isolated and identified. Its cells and metabolites were obtained by culturing in culture medium and showed inhibitory activity against a variety of bacteria and tumor cells.
The white horse amycotic acid bacterium WQ 127309 has shown significant inhibitory activity against a variety of bacteria and tumor cells, possessing broad-spectrum antibacterial and antitumor potential, and providing a new resource for antibiotics and antitumor drugs.
Smart Images
Figure CN119060905B_ABST